Impact of surveillance of hepatitis b and hepatitis c in patients with inflammatory bowel disease under anti-TNF therapies: multicenter prospective observational study (REPENTINA 3)

Gisbert JP Loras C; GETECCU group (Grupo Español de trabajo de Enfermedades de Crohn y Colitis Ulcerosa) REPENTINA study; Javier Calvet Calvo

Impact of surveillance of hepatitis b and hepatitis c in patients with inflammatory bowel disease under anti-TNF therapies: multicenter prospective observational study (REPENTINA 3)

Gisbert JP Loras C, GETECCU group (Grupo Español de trabajo de Enfermedades de Crohn y Colitis Ulcerosa) REPENTINA study, Javier Calvet Calvo

Department of Medicine

Research output: Contribution to journal › Article › Research

34 Citations (Scopus)

Original language	English
Pages (from-to)	1529-1538
Journal	J. Crohns Colitis
Volume	8
Publication status	Published - 1 Jan 2014

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

Loras C, Gisbert JP ; REPENTINA study, GETECCU group (Grupo Español de trabajo de Enfermedades de Crohn y Colitis Ulcerosa) ; Calvet Calvo, Javier. / Impact of surveillance of hepatitis b and hepatitis c in patients with inflammatory bowel disease under anti-TNF therapies: multicenter prospective observational study (REPENTINA 3). In: J. Crohns Colitis. 2014 ; Vol. 8. pp. 1529-1538.

@article{f48947e65db64261a447d15b6e7c2214,

title = "Impact of surveillance of hepatitis b and hepatitis c in patients with inflammatory bowel disease under anti-TNF therapies: multicenter prospective observational study (REPENTINA 3)",

author = "{Loras C}, {Gisbert JP} and {REPENTINA study}, {GETECCU group (Grupo Espa{\~n}ol de trabajo de Enfermedades de Crohn y Colitis Ulcerosa)} and {Calvet Calvo}, Javier",

year = "2014",

month = jan,

day = "1",

language = "English",

volume = "8",

pages = "1529--1538",

journal = "Journal of Crohn's and Colitis",

issn = "1873-9946",

}

Impact of surveillance of hepatitis b and hepatitis c in patients with inflammatory bowel disease under anti-TNF therapies: multicenter prospective observational study (REPENTINA 3). / Loras C, Gisbert JP; REPENTINA study, GETECCU group (Grupo Español de trabajo de Enfermedades de Crohn y Colitis Ulcerosa); Calvet Calvo, Javier.

In: J. Crohns Colitis, Vol. 8, 01.01.2014, p. 1529-1538.

Research output: Contribution to journal › Article › Research

TY - JOUR

T1 - Impact of surveillance of hepatitis b and hepatitis c in patients with inflammatory bowel disease under anti-TNF therapies: multicenter prospective observational study (REPENTINA 3)

AU - Loras C, Gisbert JP

AU - REPENTINA study, GETECCU group (Grupo Español de trabajo de Enfermedades de Crohn y Colitis Ulcerosa)

AU - Calvet Calvo, Javier

PY - 2014/1/1

Y1 - 2014/1/1

M3 - Article

VL - 8

SP - 1529

EP - 1538

JO - Journal of Crohn's and Colitis

JF - Journal of Crohn's and Colitis

SN - 1873-9946

ER -